scyther5 /
21 June 2017Americas

Hospira sued for patent infringement over allergic injections

Florida-based company Belcher Pharmaceuticals has filed a complaint against Hospira for patent infringement.

The case was filed on Friday, June 16, at the US District Court for the District of Delaware.

Belcher alleged that Hospira intends to market a generic epinephrine injection USP called Abboject.

The injection is used for emergency treatments of allergic reactions.

According to Belcher, Hospira’s plans to bring the injection to market infringe its US patent number 9,283,197, titled “More potent and less toxic formulations of epinephrine and methods of medical use”.

Belcher has asked the court for costs for bringing the case to court.

Today’s stories:

Section 101 raises fundamental question: 3M

Panellists tackle patent concerns after Brexit

FBI agent and lawyers provide trade secret tips

Industry at a crossroads over section 101

Pfizer and Takeda help to tackle Africa cancer crisis

Academic patents gave $1.3tn to US output

David Cameron talks Brexit, Trump and genomes

Teva must pay $235m to GSK

Google’s parent company invests $300m in biotech

Did you enjoy reading this story?  Sign up to our free newsletters and get stories like this sent straight to your inbox.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at